Jump to page content Accessibility
News, views and contacts from the global Drugdevelopment industry
Login to drugdevelopment-technology.com Log in or Register
  • Home
  • Products & Services
  • Company A - Z
  • Projects
  • Features
  • Videos
  • White Papers
  • News
  • Events
  • Advertise With Us
Industry Projects | Projects by Region | Projects by Category | Archived Projects | Project Gallery
 

Pradaxa – Oral Direct Thrombin Inhibitor



Pradaxa (dabigatran etexilate)

Pradaxa is a new oral anticoagulant under development by Boehringer Ingelheim. It has a rapid onset and offset of action and predictable anticoagulation action, eliminating the need for coagulation monitoring.

  • human heart
    Venous thromboembolism is the third most common cardiovascular disease after...
  • Venous thromboembolism
    Venous thromboembolism can lead to deep vein thromboses and pulmonary embolisms.
  • Risk of developing DVT or PE
    Patients undergoing major orthopaedic surgery are at an especially high risk...
  • Oral anticoagulants
    In clinical use for some 50 years, the vitamin K antagonist warfarin remains...
  • Pradaxa (dabigatran etexilate)
    Pradaxa is a new oral anticoagulant under development by Boehringer Ingelheim.

Back to Project Details



Related Projects

Ariflo (Cilomilast) - Oral PDE-IV Inhibitor for
Ariflo (cilomilast) is an oral selective phosphodiesterase (PDE) IV...

Sativex - Investigational Cannabis-Based treatment for Pain and Multiple Sclerosis
Developed by GW Pharmaceuticals, Sativex is a whole plant medicinal...

Capravirine - Anti-Retroviral Drug
Developed by Pfizer Global Research and Development, capravirine is...

Acomplia (Rimonabant) - Investigational Agent for
Developed by Sanofi-Aventis, Acomplia (rimonabant) is a selective...

Tarceva - Small Molecule
Tarceva (erlotinib) is an oral anti-cancer drug developed by...

See all projects


Contact us
Advertise with us
Terms and conditions
Privacy
Links
Newsletter sign up
Online magazine sign up

drugdevelopment-technology.com is a product of Net Resources International. Copyright 2011 Net Resources International, a trading division of SPG Media Limited.